An Observational Study for the Assessment of Compliance and Persistence to Rebif® Therapy of Patients With Relapsing-remitting Multiple Sclerosis (MS) and Evaluation of Potential Factors Influencing These Parameters
Conditions
- Multiple Sclerosis, Relapsing-Remitting
Sponsor
Merck KGaA, Darmstadt, Germany
Collaborators